Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3029958 34 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Recommendations for accurate genotyping of SARS-CoV-2 using
amplicon-based sequencing of clinical samples
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Objectives: Genotyping of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) has been instrumental in monitoring viral evolution and
transmission during the pandemic. The quality of the sequence data
obtained from these genotyping efforts depends on several factors,
including the quantity/ integrity of the input material, the technology,
and laboratory-specific implementation. The current lack of guidelines
for SARS-CoV-2 genotyping leads to inclusion of error-containing genome
sequences in genomic epidemiology studies. We aimed to establish clear
and broadly applicable recommendations for reliable virus genotyping.
Methods: We established and used a sequencing data analysis workflow
that reliably identifies and removes technical artefacts; such artefacts
can result in miscalls when using alternative pipelines to process
clinical samples and synthetic viral genomes with an amplicon-based
genotyping approach. We evaluated the impact of experimental factors,
including viral load and sequencing depth, on correct sequence
determination.
Results: We found that at least 1000 viral genomes are necessary to
confidently detect variants in the SARS-CoV-2 genome at frequencies of
>= 10%. The broad applicability of our recommendations was validated in
over 200 clinical samples from six independent laboratories. The
genotypes we determined for clinical isolates with sufficient quality
cluster by sampling location and period. Our analysis also supports the
rise in frequencies of 20A.EU1 and 20A.EU2, two recently reported
European strains whose dissemination was facilitated by travel during
the summer of 2020.
Conclusions: We present much-needed recommendations for the reliable
determination of SARS-CoV-2 genome sequences and demonstrate their broad
applicability in a large cohort of clinical samples. (C) 2021 The
Author(s). Published by Elsevier Ltd on behalf of European Society of
Clinical Microbiology and Infectious Diseases.
Έτος δημοσίευσης:
2021
Συγγραφείς:
Kubik, Slawomir
Marques, Ana Claudia
Xing, Xiaobin
Silvery,
Janine
Bertelli, Claire
De Maio, Flavio
Pournaras, Spyros
and Burr, Tom
Duffourd, Yannis
Siemens, Helena
Alloui,
Chakib
Song, Lin
Wenger, Yvan
Saitta, Alexandra and
Macheret, Morgane
Smith, Ewan W.
Menu, Philippe
Brayer,
Marion
Steinmetz, Lars M.
Si-Mohammed, Ali
Chuisseu, Josiane
and Stevens, Richard
Constantoulakis, Pantelis
Sali, Michela and
Greub, Gilbert
Tiemann, Carsten
Pelechano, Vicent
Willig,
Adrian
Xu, Zhenyu
Περιοδικό:
Clinical Microbiology and Infection
Εκδότης:
Elsevier Sci Ltd, Exeter, United Kingdom
Τόμος:
27
Αριθμός / τεύχος:
7
Λέξεις-κλειδιά:
Amplicon; Coronavirus; Genome; Genotyping; Guidelines; Next-generation
sequencing; NGS; Recommendations; SARS-CoV-2
Επίσημο URL (Εκδότης):
DOI:
10.1016/j.cmi.2021.03.029
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.